Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
All Congress filingsSearch insider filings
MORE TOOLS
WatchlistGold IntelligenceSilver IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeAll Congress filingsSearch insider filings
More research tools
ExploreGold IntelligenceSilver IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
LOOK INSIDE THE BUSINESS

Company financials.

Explore company-wide revenue, income and balance-sheet facts directly from SEC filings.

View TWST insider activity ↗

TWSTTwist Bioscience Corp

THE LATEST REPORTED YEAR

The company reported a loss.

$77.67M net loss for the year ended September 30, 2025. These are reported results, not a forecast or a stock recommendation.

Revenue$376.57MYear ended September 30, 2025
Profit or loss-$77.67MYear ended September 30, 2025
Cash from the business-$47.63MYear ended September 30, 2025
Total assets$672.44MAs of June 30, 2026
Total liabilities$226.7MAs of June 30, 2026
Cash & equivalents$117.44MAs of June 30, 2026
THE BUSINESS BEHIND THE TICKER

Revenue, over time.

Latest-filed standard financial facts · USD

$25.43M
2018-09
$54.39M
2019-09
$90.1M
2020-09
$132.33M
2021-09
$203.57M
2022-09
$245.11M
2023-09
$312.97M
2024-09
$376.57M
2025-09

Bars show magnitude; labels retain the sign. Each observation covers a reported annual period of 330–400 days; transition years can differ.

From the filing

Reported periods can differ from calendar years. Later filings may restate earlier figures. These are company-wide facts; product and geographic revenue segments are not included.

Reported periodReported valueFiledSource
October 1, 2024 – September 30, 2025$376,572,000November 17, 202510-K ↗
October 1, 2023 – September 30, 2024$312,974,000November 17, 202510-K ↗
October 1, 2022 – September 30, 2023$245,109,000November 17, 202510-K ↗
October 1, 2021 – September 30, 2022$203,565,000November 18, 202410-K ↗
October 1, 2020 – September 30, 2021$132,333,000November 21, 202310-K ↗
October 1, 2019 – September 30, 2020$90,100,000June 5, 202310-K/A ↗
October 1, 2018 – September 30, 2019$54,385,000November 23, 202110-K ↗
October 1, 2017 – September 30, 2018$25,427,000November 27, 202010-K ↗
Source and calculation details

One standard US-GAAP or IFRS concept is selected per metric, using USD only. Annual durations must be 330–400 days. Quarterly durations must be 70–110 days; year-to-date totals are excluded, and fourth quarters are never inferred by subtraction. Cash-flow quarters can therefore be sparse. Conflicting values filed on the same day are excluded. Latest-filed values are used, so these observations must not be treated as facts known in an earlier backtest.

Concept: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · Retrieved October 12, 2026

Response SHA-256: ab4d6e344a91d7c2894dc8c0601b52f05230299434ff75bf5209b39897d81702

SEC company facts

Company-wide USD figures from SEC filings. Each card keeps its own reporting date; later filings can revise earlier results.